Severe agranulocytosis in patient with Graves’ disease on second exposure to carbimazole

For half a century, antithyroid drugs (ATDs) have been the first-line treatment for Graves’ disease. ATDs, e.g. carbimazole, are associated with minor and serious adverse effects. These include rash, urticaria, arthralgia, hepatotoxicity, vasculitis, and agranulocytosis. Agranulocytosis is a potenti...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hady M Gad, Ammar W Ashor, Waqar Ahmad, Ahmed Hanafy, Barkavi Dhakshinamoorthy, Wael Elsaify, Simon Ashwell
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Bioscientifica 2026-03-01
Colección:	Endocrinology, Diabetes & Metabolism Case Reports
Materias:	graves’ disease carbimazole agranulocytosis antithyroid drugs adverse effects
Acceso en línea:	https://edm.bioscientifica.com/view/journals/edm/2026/1/EDM-25-0131.xml
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!